Anti-aging Effects of Low Molecular Weight Collagen Peptides Supplementation on Facial Wrinkles and Skin Hydration: Outcomes from a Six-Week Randomized, Double-Blind, Placebo-Controlled Trial

1. Introduction

The skin, the body's largest organ, plays a crucial role in numerous functions. Beyond its sensory capacity, it acts as a dynamic interface between the internal and external environments, enabling the continuous adaptation and acclimatization of the organism throughout its lifespan [1,2].

Collagen, a protein primarily synthesized by fibroblasts in the connective tissues, constitutes the most abundant component of the extracellular matrix of the skin, representing over 75% of the dry weight of a young and healthy human dermis [3,4]. Fibroblasts, as connective tissue cells within the dermis, play a pivotal role in the synthesis and organization of the collagen matrix. These cells exhibit sensitivity to both physical and chemical stimuli, which can trigger fibroblast activation and proliferation. Chemical stimuli operate via a key-lock mechanism, wherein small ligands bind to receptors located on the fibroblast extracellular membrane, leading to their activation. On the other hand, physical stimuli directly influence the interactions between collagen and fibroblasts [3,4].

Thus, collagen is a cornerstone in the skin`s extracellular matrix, essential for maintaining structural integrity and physiological functions. It retains water and plays a pivotal role in maintaining the skin's smoothness, firmness, and resilience [4]. This enables the skin to effectively respond to the ever-changing onslaught of environmental stressors [5].

The aging process of the skin is an ongoing phenomenon, marked by a gradual decline in structural and physiological functions, often exacerbated by environmental factors and dermatological disorders [6,7].

Aging precipitates a decline in collagen synthesis within mature skin, attributed to diminished activity of enzymes involved in collagen post-translational processing, a reduction in the population of collagen-synthesizing fibroblasts, and a decrease in skin vasculature [8,9,10]. Consequently, the skin's biomatrix begins to deteriorate as the collagen scaffold loses its strength and stability [4,11,12].

Extrinsic factors such as sunlight exposure, smoking, pollution, alcohol consumption, an unbalanced diet, and stress-related micronutrient deficiencies expedite this process, contributing to the process of collagen loss associated with aging skin [4,12,13,14]. The consequences of aging on the skin are manifold. It undergoes regressive changes, losing its integrity and becoming progressively thin and dry, leading to a compromised ability to retain enough moisture. Additionally, the reduction in dermal thickness and elasticity over time manifests as lines and wrinkles, further contributing to the visible signs of aging [15].

To counteract age-related changes and rejuvenate the biomatrix, hydrolyzed collagen has emerged as a popular and promising nutraceutical for skin anti-aging. Collagen supplements are available in various forms, including gels, liquids, capsules and powder [2,16,17,18,19].

While some studies suggest potential benefits of collagen supplementation, it is crucial to elucidate its potential implications for skin health and aging as well as to consider individual factors and preferences [19,20,21,22].

A tailored enzymatic digestion of native collagen preserves the collagen-specific secuence Gly-Pro-Hyp (GPH) and yields a low molecular weight (LMW) hydrolysate, enriched with this active tripeptide that seems to exert beneficial effects in various tissues, including skin, muscles, joints and bones [23,24,25]. Therefore, COLLinstant LMW, a novel cosmeceutical with low molecular weight (≤ 1000 Da) collagen peptides distinguishes itself, in contrast to other regular collagen hydrolysates, by containing a high proportion of small GPH active peptides that could improve the bioavailability, mode of action and thereby, the efficacy of the product.

The objective of the present study is to assess the effectiveness of daily supplementation with COLLinstant® LMW over a period of six weeks in ameliorating visible signs of aging. This includes assessing its impact on skin wrinkle reduction, as well as its potential to enhance skin elasticity and moisturization. COLLinstant® LMW was administered orally in a single-center, randomized, double-blind, placebo-controlled clinical trial. A secondary objective involves comparing skin improvement, assessing product satisfaction, and monitoring adverse events among middle-aged female volunteers.

2. Materials and Methods

2.1. Study Design and Ethical Aspects

This was a 6-week, prospective, randomized, placebo-controlled, double-blind, monocentric study performed at GALA Laboratories in Don Benito-Villanueva (Badajoz, Spain). This study is listed on the Clinical Trials.gov registry (NCT06321770).

Participants were individually randomized (1:1 ratio) to a strategy of receiving either COLLinstant LMW (collagen group) or a placebo regimen and were followed up for 6 weeks. Subjects were instructed to follow the administration guidelines provided in the manufacturer's package for both product regimens and, if necessary, investigator guidance.

The investigation was performed according to the ethical guidelines detailed in the Declaration of Helsinki (amendment of the 64th General Assembly, Fortaleza, Brazil, October 2013) and with national regulations of Spain, and in full compliance with the applicable principles of good clinical practice (GCP) and International Council for Harmonisation (ICH) of Technical Requirements for Pharmaceuticals for Human Use [26]. The trial protocol was approved (code 075-2022) by the Clinical Research Ethics Committee at the University Hospital of Cáceres (Caceres, Spain) and written informed consent was obtained from all subjects prior to any study procedures being initiated.

2.2. Investigational Product

The preparation under study was COLLinstant® LMW (Viscofan DE GmbH, Weinheim, Germany), an oral food supplement based on bovine bioactive hydrolyzed type I and III-collagen peptides.

Following ICH-GCP requirements and applicable local regulations[26], the investigational product and placebo were formulated as powder-containing sachets for oral suspension that were identical in appearance and odor.

Each sachet of the investigational product (COLLinstant® LMW) contained low molecular weight hydrolyzed 2.5 g collagen peptides. Other ingredients, which were also contained in the placebo, were 467 mg lemon flavour, 150 mg anhydrous citric acid, 8.5 mg sucralose and 7.1 mg stevia (97%). The placebo did not contain any nutrients.

2.3. Study Subjects

We recruited a total of 80 women (aged 30-65 years) with phototypes I-IV (Fitzpatrick scale) [27], who were mentally and physically healthy, had a BMI 20.0-29.9 kg/m2 and displayed visible signs of natural and photoaging on their face (crow´s feet) rated from moderate to severe [28].

The Fitzpatrick scale is a numerical classification system for human skin color, ranging from type I to type VI, based on the amount of melanin in the skin. This classification informs the skin's susceptibility to burns and its ability to tan [27,29].

During the screening phase, participants met all inclusion and exclusion criteria and agreed to refrain from prolonged exposure to ultraviolet (UV) radiation throughout the study duration. Subjects were excluded if they were pregnant or lactating, had acute or chronic skin diseases or dermatological disorders, used natural health supplements for skin improvement within one month prior to the study commencement, followed a low protein diet, had planned or unavoidable UV radiation exposure, had tattoos on or near the test area, used systemic corticosteroids or applied topical alpha hydroxy acids near the test site within four weeks of enrollment, used topical medications near the test area within six weeks of enrollment, underwent Botulinum toxin A (Botox) treatment or filler injection (collagen, hyaluronic acid, etc.) near the test sites within two years of enrolment, were cognitively impaired and/or unable to provide informed consent, or had any other condition that, in the medical investigator's opinion, might adversely affect the individual's ability to complete the study or its measures or pose significant risk to the individual.

2.4. Study Schedule and Biometric Evaluation

All participants (test and placebo groups) were instructed to consume the content of one sachet daily, in the morning, on an empty stomach for 6 weeks. It was required that the product was dissolved in at least 100 ml of water, juice or other liquid.

For all women participating in the study, skin parameters were assessed at baseline (T0), and biometric changes were also evaluated after 6 weeks of treatment with the products (T6).

Measurement of skin wrinkling parameters (volume, area and depth) was evaluated at the crow`s feet region and changes were analyzed and digitally photographed in all patients by VisioFace® 1000D (equipped with a high-resolution reflex camera) [30].

According to Mödinger et al [31] subjects underwent acclimatization for a minimum of 30 minutes in the air-conditioned measurement room set at a temperature of 21 ± 1°C and a relative humidity of 50 ± 5%.

Skin elasticity at the crow's feet region was quantified using a Cutometer® dual MPA 580 (Courage & Khazaka), a non-invasive instrument designed to assess skin biomechanical properties [32]. This device evaluates skin elasticity by applying negative force that mechanically deforms the skin. The operational principle involves using a probe with negative pressure (450 mbar) to suction the skin, drawing the test area into the probe's aperture. A non-contact optical measurement system then determines the depth of skin penetration. The evaluated parameters (R0, R2, R5, R7 y R9) are key indicators used to characterize skin biomechanical properties following suction force application [33,34,35,36,37,38,39].

R0 represents the final distension of the initial curve, reflecting the passive response of the skin to suction force and correlating with skin firmness. It is calculated as the difference between the highest point of amplitude at the end of the suction phase and the baseline reading (R0 = Uf). The R2 parameter is related to the gross elasticity/viscoelasticity, representing the skin's resistance to mechanical suction force relative to its ability to recover (R2 = Ua/Uf). R5, referred to as net elasticity, signifies the ratio of elastic deformation during suction to rapid recovery during relaxation (R5 = Ur/Ue), indicating higher skin elasticity with increasing values. R7 is related to biological elasticity, quantifying the immediate elastic recovery within the first 0.1 seconds compared to the total deformation after suction (R7 = Ur/Uf) and can be interpreted as another marker of elasticity, with aging causing its reduction. Lastly, R9 denotes residual deformation at the conclusion of the measurement cycle, reflecting skin fatigue following repeated suction (R9 = R3 - R0) [32,37,38,40,41]. The measurements were carried out in triplicate.

Furthermore, stratum corneum hydration was assessed at each study visit using the electrical capacitance method with a Corneometer® CM 825 (Courage & Khazaka, Cologne, Germany). A minimum of five measurements were taken per measurement area at four distinct locations (middle forehead, both cheekbones, and the chin area), and the average value was used for subsequent analysis [31,39,41].

2.5. Safety and Self-Reported Measures

Safety was evaluated based on adverse reactions reported by the patients during the treatment period. Adverse events were documented at the final visit following six weeks of treatment.

After 6 weeks of treatment, the volunteers filled out questionnaires, to subjectively assess their perception of different parameters such as efficacy, organoleptic properties, tolerability and satisfaction since the last time they took the product. The Spanish version of the Treatment Satisfaction Questionnaire with Medication (TSQM) [42], and a 3-point Likert scale with the following items: Dissatisfied, slightly satisfied and very satisfied, were used.

2.6. Statistical Methods

All statistical analyses were performed using IBM® SPSS® Statistics for Windows (version 27.0) and JASP [43]. The analysis of the distribution and normality tests of the variables were carried out using the Shapiro-Wilk tests.

All measured data are presented as mean ± SD (standard deviation). Categorical variables were summarized using the number and percentages of patients in each category. Skin parameters (wrinkling, elasticity, and hydration) were evaluated descriptively at baseline (T0) and after 6 weeks of collagen supplementation (T6). The efficacy was assessed based on relative changes in these parameters, calculated as the differences between means at T0 and T6.

Graphical representations of the results were generated using box-and-whisker plots. The box spans from the 25th to the 75th percentile of the data. Whiskers extend from the edges of the box to the minimum and maximum values that are not considered outliers. Outliers, defined as values more than 1.5 times the interquartile range from the box, are depicted as symbols beyond the whiskers.

The between-group comparison (placebo group vs. verum group) was carried out to determine population homogeneity at baseline (T0); and, to analyse treatment-related differences after 6 weeks (at T6) by means of the Mann-Whitney U test, a non-parametric test applied to two independent samples. Comparisons between categorical variables are performed using the Chi-square test.

The within-group mean changes of skin parameters between the initial (T0) and final (T6) visits were evaluated by the non-parametric Wilcoxon signed-rank test, for paired data. The threshold of statistical significance was set, in all cases, for a value of p < 0.05.

3. Results

3.1. Consort (Consolidated Standards of Reporting Trials) Flowchart of the Controlled Interventional Trial

Eighty women aged 30 to 60 years were included in the statistical analysis. No subjects were excluded during screening or throughout the study, and no protocol violations occurred. Compliance during the trial was excellent; therefore, all volunteers (n= 80) who were screened for eligibility and requested to participate, completed the study protocol, and could therefore be analysed. The flow of subjects through the controlled intervention trial is depicted in a diagram according to CONSORT guidelines (Figure 1) [44].

3.2. Characteristics of the Population

Participants (n= 80) were randomized at baseline (T0) and allocated to the verum group (n= 40) or the placebo group (n= 40). Demographic and general features of the volunteers did not show any significant difference between the test product and the placebo group at baseline (Table 1).

The investigational treatment group included 40 women who received the bioactive collagen peptide-based food supplement orally.

The mean age in the placebo group (n= 40) was 47 ± 7.7 years (age range between 32 and 60 years); and in the experimental group (n= 40), 45 ± 7.1 years (age range between 30 and 58 years), with no significant differences between the two groups (p = 0.22).

The predominant skin type in both groups (placebo and experimental) was "normal skin" (67.5% in the experimental group vs. 75% in the placebo group), followed by "sensitive skin" (30% in the experimental group vs. 20% in the placebo group), with no significant differences between the two groups (p = 0.27).

Among all participants, the most represented Fitzpatrick skin classification was phototype III (slightly brown skin and brown hair) that was predominant in both groups (90% in the placebo group; 85% in the verum group). No significant differences were detected between the two groups for this dermatological parameter (p = 0.20).

Homogeneity tests between groups revealed no significant differences for the mean initial skin parameters at baseline (T0) between the placebo group and the collagen group (Table 2).

3.3. Skin Wrinkling

The descriptive analysis of skin wrinkling biometric parameters (volume, area and depth) of the facial crow`s feet region, before intake of the product (at T0), and after 6 weeks of intake (at T6), is summarized in Table 3. The mean value of three determinations was used for analysis. At baseline the mean skin wrinkling biometric parameters were similar between both groups of treatment (Table 2). Regarding the intraindividual comparison from baseline (T0-T6), all biometric parameters (volume, area and depth) considerably improved at T6, after 6 weeks of treatment in the collagen group, whereas they remained unchanged in the placebo group during the same period (Table 3).

At baseline (T0), no significant differences were found for the mean skin wrinkle volume at the crow`s feet region between the placebo group (48.50 px³) and the collagen group (58.77 px³) (Table 2). After 6 weeks of intake of the study products, at T6, the mean volume of wrinkles significantly decreased from baseline (T0-T6) by -45.9% [-90.8% – (-2.9%)] in the collagen group (58.77 vs. 30.24 px³; p < 0.001) but remained relatively unchanged by 0.32% (-90.4% - 20.9%) in the placebo group (48.50 vs. 50.30 px³) (Table 3 and Figure 2). The difference between groups (placebo vs. collagen) at T6 proves to be significant (p < 0.01) in favor of the test product (Table 3 and Figure 2).

Starting at baseline from similar initial mean wrinkle area of 4.13 px² (placebo group) and 4.53 px² (collagen group) (Table 2), after an intake of 6 weeks of either placebo or collagen, the area of skin wrinkle at crow`s feet region significantly decreased from baseline (T0-T6) by -43.8% [-94.4% – (-2.6%)] (4.53 vs. 2.60 px²; p < 0.001) in the collagen group, but the intraindividual difference was almost negligible by 1.66% (-24.6% – 41.7%), in the placebo group (4.13 vs. 4.14 px²) (Table 3 and Figure 3). At T6, the intergroup comparison (placebo group vs. collagen group) of the mean wrinkle area proved to be significant (p < 0.001) in favor of the test product (Table 3 and Figure 3).

Table 2 shows that mean wrinkle depth values were similar at baseline of 11.95 px (placebo) and 11.50 px (collagen group). However, in line with improvements in volume and area, skin wrinkle depth decreased during intake of the investigational product. As shown in Table 3 and Figure 4, at T6, the depth of wrinkles significantly decreased from baseline (T0-T6) by -9.0% (-40.0% – 0.0%) (11.50 vs. 10.35 px; p < 0.001) in the collagen group. On the other hand, the intraindividual variation was non-significant and limited to 3.3% (-33.3% – 40.0%) (11.95 vs. 12.25 px) in the placebo group. The differences between the groups at T6 (placebo group vs. collagen group) of the mean wrinkle depth proved also to be highly significant (p < 0.001) in favor of the test product (Table 3 and Figure 4).

Figure 5 illustrates photographs of three volunteers showcasing the improvement from the initial visit at T0, in facial wrinkling following the consumption of the investigational product COLLinstant^® LMW for six weeks. The skin assessment was conducted using objective and validated methods (Visioface 1000D). In volunteer no. 13, there was a percentage change in volume, area, and depth of -59.18%, -51.91%, and -15.4%, respectively. For volunteer no. 60, the corresponding changes were -64.8%, -46.2%, and -40.0%, and for volunteer no. 70, the changes were -37.1%, -31.4%, and -7.2%, respectively.

3.4. Skin Elasticity

The descriptive analysis of skin elasticity obtained from the Cutometer^® device before intake of the product (at T0) and after 6 weeks of intake (at T6) is summarized in Table 4. The mean value of three determinations at the crow's feet region was used for analysis. At baseline (T0) the skin elasticity parameters were similar between both groups of treatment (Table 2).

Results showed that skin firmness (R0) significantly increased in both groups of treatment. Compared to baseline (T0), the assessment of total elongation and skin firmness (R0) showed statistically significant lower values (p < 0.001) after 6 weeks in both the group of treatment receiving placebo and the collagen group (Table 4). At the end of the study, at T6, we could not demonstrate significant differences in the R0 parameter between both group means (Table 4).

The percentage of variation in mean skin firmness (R0) from baseline was -8.6% (-50.8% - 24.1%) in the placebo and -10.7% (-61.3 % - 29.0 %) in the group that received the food supplement.

The assessment of the remaining skin elasticity parameters (R2, R5, R7 and R9) showed a moderate improvement, but the differences were not statistically significant (Table 4).

At T6, the assessment of the rest of skin elasticity parameters (R2, R5, R7 and R9) obtained with the Cutometer^® device did not show any statistical significance between groups (Table 4) indicating that the food supplement did not show an improvement in most skin elasticity parameters in our study.

3.5. Skin Hydration

The descriptive analysis of skin hydration before intake of the product (at T0) and after 6 weeks of intake (at T6) is summarized in Table 5. The mean value of five determinations at four different locations (middle forehead, both right and left cheek and the chin) was used for analysis. At baseline (T0) the skin hydration values were similar between both groups of treatment, 54.77 AU (placebo group) vs. 55.50 AU (collagen group) (Table 2).

Corneometric methodology corroborated the improvement in skin hydration in the volunteers who received the test product. Compared to baseline (T0), it has been detected a statistically significant improvement in skin hydration by +34.4% (9.2% - 98.0%) (55.50 AU vs. 74.13 AU, p < 0.001) in the volunteers who received the investigational product for 6 weeks (T0-T6) (Table 5). On the other hand, the percentage change in skin hydration was non-significant and limited to +1.0% (-30.3% - 17.6%) (54.77 vs. 55.03 AU) in the placebo group (Table 5 and Figure 6). The differences between the groups at T6 (placebo group vs. collagen group) of the mean hydration values proved to be highly significant (p < 0.001) in favor of the test product (Table 5 and Figure 6).

3.6. Overall Assessment of the Efficacy

Compared with placebo, the efficacy of the test product is summarized in Figure 7. The differences between the relative changes (T0-T6) in skin wrinkle parameters (volume, area and dept), skin elasticity and skin hydration are illustrated. There was a statistically significant improvement (p < 0.001) in the skin wrinkle parameters and skin hydration in the collagen group. Regarding skin elasticity, the food supplement had only slight beneficial effects on skin elasticity parameters but we could not demonstrate statistical significance.

3.7. Safety and Subjective Rating

During the study intervention, the collagen supplement did not cause any side effects and proved to be safe and well tolerated during the entire period of application.

Over two thirds of the volunteers rated the overall effectiveness of COLLinstant^® LMW as good, a survey result that was matched by the ratings of the treating physicians. Over 90% of the volunteers in the experimental group indicated a high degree of satisfaction with the ability of the supplement to improve skin hydration or wrinkles, confirming the robust effect of the treatment. In addition, 87.5% of the volunteers in this group was highly satisfied with the brief time period it takes for the supplement to start showing its effect, underlining the significance of obtaining quick results with a collagen food supplement.

Table 6. Results of the survey conducted by the principal investigators with the volunteers who received the food supplement.

Table 6. Results of the survey conducted by the principal investigators with the volunteers who received the food supplement.

4. Discussion

Skin aging involves an intricate number of biological processes characterized by changes that affect several components of the skin over time, influencing its appearance as an individual ages [45]. Intrinsic skin aging, driven by factors like genomic instability, cellular senescence, and telomere shortening, contributes to declining skin function and appearance. Additionally, external factors such as UV radiation, pollution, tobacco smoke, and alcohol consumption accelerate this process, leading to premature, hastening this process and contributing to early skin aging [45,46].

The psychosocial impact of skin aging has spurred the demand for effective interventions, including topical creams, injectable fillers, and collagen supplements [2,47].

While topically applied collagen from skincare products such as creams, lotions, and serums often fail to penetrate the deeper layers of the skin [2,48], collagen supplements, particularly those containing hydrolyzed collagen, have emerged as a safe and cost-effective option, gaining popularity in recent years as a strategy to enhance skin health and maintain a youthful appearance [4,19,47,49,50,51].

In this context, COLLinstant® LMW, a novel cosmeceutical containing low molecular weight collagen peptides, was selected for the clinical trial. The study specifically aimed to assess the efficacy, safety, and tolerability of 2.5 g COLLinstant® LMW over a 6-week period, specifically assessing various skin parameters. We have demonstrated a significant reduction in some skin wrinkle biomarker indicators such as volume, area, and depth at crow's feet region. Additionally, compared with placebo, increased skin hydration and moderate improvement in skin elasticity were also found. However, we were unable to demonstrate differences in the parameters that assessed skin elasticity between the control group and the investigational group. The effects were exclusive to COLLinstant® LMW, as the subjects had no other form of cosmetic treatment.

Ingesting hydrolyzed collagen and in particular, low molecular weight collagen hydrolysate, has been shown as a promising and useful strategy to improve skin hydration and elasticity and thus, to counteract the changes associated with skin aging [2,4,52]. COLLinstant® LMW is orally administered, making them easy to incorporate into daily routines. Nevertheless, not all sources of hydrolyzed collagen are equally effective, and further studies are warranted to determine the optimal source and therapeutic duration against skin aging. Different types of collagen used in these supplements, such as fish, porcine, chicken, and bovine collagen, may exhibit varying effects based on their source [2,4,53,54].

In the context of skincare and nutraceuticals, hydrolyzed bovine collagen has become a popular ingredient. COLLinstant® LMW has been the first bovine collagen hydrolysate in the market, providing a beneficial amino acid profile that serves as building material and stimulator for the synthesis of new collagen, elastin and hyaluronic acid in the skin as corroborated in different studies [54]. The remarkable improvements in skin parameters observed in this investigation may be attributed to the substantial similarity between the collagen peptides derived from the bovine collagen complex and those naturally present in human collagen. Indeed, the hydrolysis of bovine collagen yields specific bioactive short-chain peptides that closely match the amino acid profile of human collagen I, as well as elastin and hyaluronic acid within the skin [4,55,56,57,58,59,60]. This chemical resemblance likely contributes to the efficacy of the supplementation in enhancing skin health and appearance.

During the aging process, the relationship between enzymes and collagen turnover is complex. A pivotal molecular event is the dysregulation of extracellular matrix turnover, particularly the degradation of collagen fibers by matrix metalloproteinases (MMPs) and other proteases [45]. Consequently, the skin undergoes structural changes, including a thinning and a reduction in epidermal thickness, along with damage to the dermis [61,62]. These structural changes result in regressive changes such as dehydration and loss of elasticity, leading to dry and loose skin with the appearance of furrows or wrinkles [45,63,64]. According to the findings by Oesser et al. [65], the observed improvements in our study are likely attributable to changes in protein turnover and the restoration of collagen synthesis within the dermal stratum of the skin. This was notably manifested in our study through increases in the volume, area, and depth of skin wrinkles following oral supplementation with collagen.

The importance of dosage and duration of the treatment emerged as crucial factors to be considerated. In contrast with the higher dosages and longer durations recommended for standard molecular weight collagen hydrolysates to achieve clear beauty or health benefits [17,66] notably, a daily intake of 2.5 g COLLinstant® LMW for 6 weeks was sufficient to yield beneficial effects on some biometric parameters of skin health in this study.

Regarding improvement on skin elasticity, our findings indicated a positive trend (as measured by the Cutometer) in the group treated with the investigational product. However, the observed differences did not attain statistical significance when compared with the placebo group. In order to obtain efficacy in enhancing skin elasticity through hydrolysed collagen supplementation a more prolonged treatment, exceeding 8 weeks, could be necessary [54].

Collagen is characterized by a triple helix structure formed by the repetition of glycine every third residue, and particularly by proline and hydroxyproline in the other residues [67,68]. In this context, COLLinstant® LMW has a unique composition enriched with bioactive glycine- and proline-rich peptides that may help to increase efficacy of the product.

It has been demonstrated that the administration of collagen peptides can positively impact on various skin conditions and aging [4,54,56]. These amino acids are crucial in the structure of collagen, and their presence in the form of bioactive peptides enhances gastrointestinal absorption [3], making it highly bioavailable and detectable in human blood shortly after ingestion [69,70]. While normal weight collagen is degraded in the gastrointestinal tract but not readily cleaved into bioactive peptides, GPH and PH enriched in LMW collagen easily cross the intestinal barrier into the blood stream via the peptide transporter PEPT1 and remain intact over the entire gastrointestinal pathway [23,71,72].

The efficacy of bioactive collagen di- and tripeptides in enhancing skin health appears to be attributed to several key mechanisms. First, the ability of these compounds to induce collagen expression through the mitogen-activated protein kinase 38 (p38 MAPK) pathway.[73] Secondly, an increased availability of essential free amino acids to promote the synthesis of collagen and elastin fibers. Third, they have the potential to stimulate fibroblasts to produce collagen and hyaluronic acid [3,4,74,75,76,77].

The tested product of collagen supplementation was demonstrated to be safe, and no adverse effects were reported. Furthermore, the beneficial effects of collagen intake were not only fully validated through objective testing methods but also in the subjective assessments provided by the volunteers.

5. Conclusions

Exploring its potential as a natural intervention to uphold skin health and combating signs of aging, low molecular weight collagen peptides (COLLinstant® LMW) were investigated in a randomized, placebo-controlled clinical trial, following a daily oral supplementation of 2.5g of these peptides.

LMW collagen hydrolysate with a high concentration of these characteristic peptides has major advantages over standard molecular weight products, including quicker and more efficient peptide uptake, higher bioavailability, as well as enhanced stability and efficacy, especially in the skin.

The study substantiated the efficacy of these nutrients in restoring altered skin biometric parameters, as objectively assessed. We observed a significant reduction in wrinkles, a considerable increase in skin hydration, and modest improvements in skin elasticity. Regular supplementation may contribute to achieving smoother and more radiant skin.

A continuous supplementation has the potential to enhance skin texture by providing essential building materials in this tissue, stimulating the synthesis of new collagen, elastin, and hyaluronic acid. Importantly, the collagen supplementation regimen has been found to be devoid of any adverse effects, proving to be safe and well-tolerated throughout the entire administration period.